Cognition Therapeutics, Inc. (CGTX)
NASDAQ: CGTX · Real-Time Price · USD
1.290
-0.070 (-5.15%)
At close: Jun 5, 2026, 4:00 PM EDT
1.350
+0.060 (4.65%)
After-hours: Jun 5, 2026, 7:59 PM EDT
Cognition Therapeutics Market Cap
Cognition Therapeutics has a market cap or net worth of $115.27 million as of June 5, 2026. Its market cap has increased by 484.15% in one year.
Market Cap
115.27M
Enterprise Value
79.09M
1-Year Change
484.15%
Ranking
Category
Stock Price
$1.29
Market Cap Chart
Since the IPO on October 8, 2021, Cognition Therapeutics's market cap has decreased from $256.46M to $115.27M, a decrease of -55.05%. That is a compound annual growth rate of -15.77%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 5, 2026 | 115.27M | -3.28% |
| Dec 31, 2025 | 119.17M | 308.99% |
| Dec 31, 2024 | 29.14M | -50.97% |
| Dec 29, 2023 | 59.43M | -2.39% |
| Dec 30, 2022 | 60.88M | -56.29% |
| Dec 31, 2021 | 139.27M | -45.69% |
| Oct 8, 2021 | 256.46M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Alpha Cognition | 126.73M |
| Kazia Therapeutics | 125.58M |
| TuHURA Biosciences | 125.14M |
| Alps Group | 118.14M |
| Black Diamond Therapeutics | 112.88M |
| Pyxis Oncology | 112.77M |
| NeOnc Technologies Holdings | 111.90M |
| Polaryx Therapeutics | 110.31M |